Literature DB >> 729611

Comparison of the duration of action of pindolol and slow release oxprenolol in healthy volunteers.

W H Aellig.   

Abstract

The duration and extent of the reduction of exercise-induced tachycardia, as a measure of cardiac beta-adrenoceptor blockade were studied in 12 healthy volunteers after administration of single oral doses of pindolol 15 mg (Visken) or 160 mg slow release oxprenolol (Slow-Trasicor). The mean maximum effect was reached after 1.6 +/- 0.3 h with pindolol and after 2.5 +/- 0.2 h with slow release oxprenolol. The reduction in heart rate during exercise was virtually identical after both drugs, amounting to -36.1 +/- 1.7 beats/min after pindolol and -36.3 +/- 1.6 beats/min after slow release oxprenolol. The duration of action of pindolol, however, was clearly longer than that of slow release oxprenolol: after 24 h pindolol still exerted 39.6 +/- 5.6% of its maximum activity, as against 22.1 +/- 3.6% for slow release oxprenolol.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 729611     DOI: 10.1007/bf02089955

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  [Plasma level of pindolol (Visken) under long-term treatment, computed from pharmacokinetics after a single dose].

Authors:  R Gugler; G Bodem; H J Dengler
Journal:  Verh Dtsch Ges Inn Med       Date:  1976

2.  Slow release oxprenolol in angina pectoris [proceedings].

Authors:  P W Goldstraw; S H Taylor; U Thadani; S J Watt
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

3.  Initiation of once-daily pindolol treatment.

Authors:  G Frithz
Journal:  Br Med J       Date:  1978-02-04

4.  Dosage schedules in general practice.

Authors: 
Journal:  Practitioner       Date:  1970-05

5.  A comparison of slow release with conventional oxprenolol: plasma concentrations and clinical effects.

Authors:  M J West; M J Kendall; M Mitchard; E B Faragher
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

6.  [The practice of hypertensive therapy using a beta receptor blocker. A multicentric study using 15 mg Visken].

Authors:  J Rosenthal; H Kaiser; D Hammerschmidt; D Welzel
Journal:  Med Welt       Date:  1977-12-02

7.  Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris.

Authors:  B F Robinson
Journal:  Circulation       Date:  1967-06       Impact factor: 29.690

8.  beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

9.  Drug defaulting in a general practice.

Authors:  A M Porter
Journal:  Br Med J       Date:  1969-01-25

10.  Once daily administration of a beta-blocker in hypertension.

Authors:  M Watt; T D Duncan
Journal:  N Z Med J       Date:  1978-02-22
  10 in total
  6 in total

1.  Pharmacokinetic comparison of pindolol 30 mg retard and 15 mg normal tablets.

Authors:  W H Aellig; E Nüesch; W Pacha
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

2.  Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol.

Authors:  W J Leahey; J D Neill; M P Varma; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1980-06       Impact factor: 2.953

Review 3.  Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  D W Harron; K L Goa; H D Langtry
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

Review 4.  Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

5.  Comparison of the effect of pindolol and propranolol on heart rate after acute and chronic administration.

Authors:  M B Finch; P C O'Connor; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

6.  A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet.

Authors:  W H Aellig; H H Narjes; E Nüesch; R J Oertle; J E Devos; W Pacha
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.